Diabetes Research Foundation), the US Centers for Medicare and Medicaid Services (CMS) has recognized continuous glucose monitors (CGMs) approved by the US FDA for use in making diabetes treatment decisions as "durable medical equipment," meaning they could soon be eligible for coverage by CMS. ...